Drug substance / API
Eurofins CDMO provides solutions for the development and biomanufacturing of a diverse range of biologics, including antibodies, proteins, enzymes, live biotherapeutic products and various types of bacteria.
Biologics drug substance
We support early-stage innovation with small-scale, non-GMP batches for activity studies, produced cost-efficiently in segregated facilities. Our scalable setup ensures a smooth path to larger production and future regulatory compliance.
Latest insights and resources
